The lack of a succession plan at Thyrocare could be a key reason for the company’s founder, Dr A Velumani, to sell the company, the report mentioned.from Top Business News- News18.com
Read The Rest:timesnownews...
PharmEasy in Advanced Talks to Acquire Thyrocare for Rs 7,000 crore: Report
 
        Reviewed by Team Exprssnews
        on 
        
June 17, 2021
 
        Rating: 
      
No comments: